XML 24 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income
Non- controlling Interests
Beginning balance (in shares) at Dec. 31, 2020   236,000,000        
Beginning balance at Dec. 31, 2020 $ 4,843 $ 2 $ 4,519 $ 376 $ (4) $ (50)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation, net 14   14      
Net income (loss) (452)     (459)   7
Other comprehensive income 4       4  
Distributions to noncontrolling interests (6)         (6)
Ending balance (in shares) at Dec. 31, 2021   236,000,000        
Ending balance at Dec. 31, 2021 4,403 $ 2 4,533 (83) 0 (49)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation, net 15   15      
Net income (loss) 173     162   11
Other comprehensive income 0          
Dividends and dividend equivalents [1] (63)     (63)    
Repurchase of common stock, (in shares)   (12,000,000)        
Repurchase of common stock (227)   (227)      
Distributions to noncontrolling interests $ (10)         (10)
Ending balance (in shares) at Dec. 31, 2022 224,061,745 224,000,000        
Ending balance at Dec. 31, 2022 $ 4,291 $ 2 4,321 16 0 (48)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation, net (in shares)   1,000,000        
Share-based compensation, net 16   15 1    
Net income (loss) 106     97   9
Other comprehensive income 0          
Dividends and dividend equivalents [1] (458)     (458)    
Repurchase of common stock, (in shares)   (15,000,000)        
Repurchase of common stock (180)   (180)      
Distributions to noncontrolling interests $ (7)         (7)
Ending balance (in shares) at Dec. 31, 2023 209,987,581 210,000,000        
Ending balance at Dec. 31, 2023 $ 3,768 $ 2 $ 4,156 $ (344) $ 0 $ (46)
[1] Dividends declared per common share were $0.28 and $2.15, which includes a special cash dividend of $0.77 per common share, for the years ended December 31, 2022 and December 31, 2023, respectively.